BroadOak, and its principals, are active investors in life sciences companies having participated in over 25 investments in the public and private markets.
The firm currently seeks opportunities to invest growth capital into companies within our industry focus through its affiliate, The BroadOak Fund.
Our Investment Approach:
- Provide growth capital to life sciences tools and service providers that have achieved a level of commercial success
- Focus on the enterprises’ total value and to a lesser extent on specific collateral or profitability metrics
- Offer flexible investment alternatives to companies with specific growth capital needs